The clinical analysis of reteplase thrombolytic therapy in 25 cases with acute myocardial infarction
ZHAO Gui-lan
WANG Guo-yan
ZHANG Hai-wen
Abstract：Objective: To observe the efifcacy and safety of reteplase on the treatment of acute ST elevation myocardial infarction. Methods:A total of 25 cases of patients with acute myocardial infarction who were eligible for thrombolysis were treated with reteplase 18 mg by slow intravenous injection (about 2 minutes or more), and reteplase was given again after half an hour. The coronary recanalization rate, adverse reactions and mortality were observed. Results:The total thrombolytic recanalization rate was 92%, it was 100%in the patients used reteplase within 2 h, and 88.9%within 2- 6 h. Conclusion:Reteplase is a safe, reliable, convenient and efifcient drug on the treatment of acute myocardial infarction, which can be used widely in the primary hospital with no condition for interventional therapy.
Keywords：ReteplaseAcute myocardial infarctionThrombolytic therapy
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 9-10 )